PPD DEVELOPMENT LP

PPD DEVELOPMENT LP specializes in end-to-end research and development support for biomedical and life sciences initiatives, with deep expertise in clinical trial design, regulatory strategy, and patient-reported outcome measurement. The firm delivers technical services spanning pre-submission package preparation for medical devices, immunogenicity assay development, pharmacokinetic studies, and clinical site monitoring—particularly for infectious disease, cardiovascular-kidney-metabolic, and respiratory therapeutics. Their work consistently supports FDA and NIH-aligned programs, emphasizing compliance with Good Clinical Practice, protocol optimization, and real-world data integration to accelerate therapeutic development pipelines. A key differentiator is their focus on complex, multi-center trials requiring rigorous statistical design and patient-centric outcome metrics, especially in diverse and underserved populations. The contractor maintains a dominant presence with the Department of Health and Human Services, providing critical R&D services to agencies including NIAID, BARDA, and CDC. Their engagements center on supporting public health emergencies, vaccine development, and novel therapeutic evaluation, often under fast-track or emergency authority frameworks. Work for HHS consistently involves direct alignment with clinical research infrastructure, regulatory submission readiness, and biomarker validation—demonstrating a trusted, recurring partnership built on scientific rigor and operational agility. Industry focus is squarely on biotechnology and life sciences R&D, with primary activity in NAICS 541714 and 541715, reflecting expertise in translational research, clinical trial support, and regulatory consulting for biologics and medical devices. The firm positions itself as a niche provider for high-complexity, government-funded biomedical innovation, bridging academic research with federal regulatory pathways. PPD DEVELOPMENT LP is a small business structured as a 2L entity, headquartered in Wilmington, NC, with no federal certifications on record. Their market positioning is defined by technical depth in clinical and regulatory science rather than scale or certifications, serving as a specialized contractor for mission-critical HHS research initiatives.